Australian-New Zealand Clinical Trial: CLEAR-PFAS Study: A randomised controlled trial of regular plasma donation to reduce PFAS concentrations and non-calcified coronary plaque volume in adults with elevated PFAS exposure and non-calcified coronary artery plaque

Australia, Nov. 10 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘CLEAR-PFAS Study: A randomised controlled trial of regular plasma donation to reduce PFAS concentrations and non-calcified coronary plaque volume in adults with elevated PFAS exposure and non-calcified coronary artery plaque’. The following are the other relevant details related to the trial:

Trial ID: 392829

Submit Date: 10/19/26 14:37

Study Type: Interventional

Intervention: Intervention: Regular plasma donation (plasmapheresis) Participants eligible for the intervention arm of the study will be randomised to immediate or deferred plasma donation. Participants randomised to immediate plasma donation will...